Belhaven Biopharma Raises $11M to Advance Nasdepi(R): The Dry Powder Nasal Breakthrough for Anaphylaxis
Oversubscribed Seed Round Accelerates Nasdepi®'s Journey as the First Dry Powder Nasal, Heat-Stable Treatment for Anaphylaxis RALEIGH, NORTH CAROLINA /...